365 related articles for article (PubMed ID: 33636209)
1. Melatonin exerts protective effects on diabetic retinopathy via inhibition of Wnt/β-catenin pathway as revealed by quantitative proteomics.
Yan M; Wang H; Gu Y; Li X; Tao L; Lu P
Exp Eye Res; 2021 Apr; 205():108521. PubMed ID: 33636209
[TBL] [Abstract][Full Text] [Related]
2. Melatonin maintains inner blood-retinal barrier via inhibition of p38/TXNIP/NF-κB pathway in diabetic retinopathy.
Tang L; Zhang C; Yang Q; Xie H; Liu D; Tian H; Lu L; Xu JY; Li W; Xu G; Qiu Q; Liu K; Luo D; Xu GT; Zhang J
J Cell Physiol; 2021 Aug; 236(8):5848-5864. PubMed ID: 33432588
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of streptozotocin-induced diabetic retinopathy with low molecular weight fucoidan via inhibition of vascular endothelial growth factor.
Yang W; Yu X; Zhang Q; Lu Q; Wang J; Cui W; Zheng Y; Wang X; Luo D
Exp Eye Res; 2013 Oct; 115():96-105. PubMed ID: 23810809
[TBL] [Abstract][Full Text] [Related]
4. Thioredoxin-interacting protein deficiency ameliorates diabetic retinal angiogenesis.
Duan J; Du C; Shi Y; Liu D; Ma J
Int J Biochem Cell Biol; 2018 Jan; 94():61-70. PubMed ID: 29203232
[TBL] [Abstract][Full Text] [Related]
5. Dickkopf-1 exerts protective effects by inhibiting PANoptosis and retinal neovascularization in diabetic retinopathy.
Xu X; Lan X; Fu S; Zhang Q; Gui F; Jin Q; Xie L; Xiong Y
Biochem Biophys Res Commun; 2022 Aug; 617(Pt 2):69-76. PubMed ID: 35691117
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin maintains VE-cadherin expression and barrier function in experimental diabetic retinopathy via inhibiting VEGF/VEGFR2/Src signaling pathway.
Liu D; Xu H; Zhang C; Xie H; Yang Q; Li W; Tian H; Lu L; Xu JY; Xu G; Liu K; Sun X; Xu GT; Zhang J
Life Sci; 2020 Oct; 259():118273. PubMed ID: 32800831
[TBL] [Abstract][Full Text] [Related]
7. LncRNA-MALAT1 promotes neovascularization in diabetic retinopathy through regulating miR-125b/VE-cadherin axis.
Liu P; Jia SB; Shi JM; Li WJ; Tang LS; Zhu XH; Tong P
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988072
[No Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor-A
Ved N; Hulse RP; Bestall SM; Donaldson LF; Bainbridge JW; Bates DO
Clin Sci (Lond); 2017 Jun; 131(12):1225-1243. PubMed ID: 28341661
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin protects the inner blood-retinal barrier by inhibiting microglia phagocytosis via Src/Akt/cofilin signalling in experimental diabetic retinopathy.
Xie H; Zhang C; Liu D; Yang Q; Tang L; Wang T; Tian H; Lu L; Xu JY; Gao F; Wang J; Jin C; Li W; Xu G; Xu GT; Zhang J
Diabetologia; 2021 Jan; 64(1):211-225. PubMed ID: 33104828
[TBL] [Abstract][Full Text] [Related]
10. LRP-1 Pathway Targeted Inhibition of Vascular Abnormalities in the Retina of Diabetic Mice.
Hossain A; Tauhid L; Davenport I; Huckaba T; Graves R; Mandal T; Muniruzzaman S; Ahmed SA; Bhattacharjee PS
Curr Eye Res; 2017 Apr; 42(4):640-647. PubMed ID: 27442082
[TBL] [Abstract][Full Text] [Related]
11. Oral supplementation with melatonin reduces oxidative damage and concentrations of inducible nitric oxide synthase, VEGF and matrix metalloproteinase 9 in the retina of rats with streptozotocin/nicotinamide induced pre-diabetes.
Djordjevic B; Cvetkovic T; Stoimenov TJ; Despotovic M; Zivanovic S; Basic J; Veljkovic A; Velickov A; Kocic G; Pavlovic D; Sokolovic D
Eur J Pharmacol; 2018 Aug; 833():290-297. PubMed ID: 29890158
[TBL] [Abstract][Full Text] [Related]
12. Repression of microRNA-21 inhibits retinal vascular endothelial cell growth and angiogenesis via PTEN dependent-PI3K/Akt/VEGF signaling pathway in diabetic retinopathy.
Lu JM; Zhang ZZ; Ma X; Fang SF; Qin XH
Exp Eye Res; 2020 Jan; 190():107886. PubMed ID: 31759996
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.
Lee K; Hu Y; Ding L; Chen Y; Takahashi Y; Mott R; Ma JX
Diabetes; 2012 Nov; 61(11):2948-57. PubMed ID: 22891217
[TBL] [Abstract][Full Text] [Related]
14. Α-Melanocyte-Stimulating Hormone Protects Early Diabetic Retina from Blood-Retinal Barrier Breakdown and Vascular Leakage via MC4R.
Cai S; Yang Q; Hou M; Han Q; Zhang H; Wang J; Qi C; Bo Q; Ru Y; Yang W; Gu Z; Wei R; Cao Y; Li X; Zhang Y
Cell Physiol Biochem; 2018; 45(2):505-522. PubMed ID: 29402864
[TBL] [Abstract][Full Text] [Related]
15. Melatonin prevents retinal oxidative stress and vascular changes in diabetic rats.
Ozdemir G; Ergün Y; Bakariş S; Kılınç M; Durdu H; Ganiyusufoğlu E
Eye (Lond); 2014 Aug; 28(8):1020-7. PubMed ID: 24924441
[TBL] [Abstract][Full Text] [Related]
16. Knockdown of Malat1 alleviates high-glucose-induced angiogenesis through regulating miR-205-5p/VEGF-A axis.
Tan A; Li T; Ruan L; Yang J; Luo Y; Li L; Wu X
Exp Eye Res; 2021 Jun; 207():108585. PubMed ID: 33887222
[TBL] [Abstract][Full Text] [Related]
17. Salutary effect of fenofibrate on type 1 diabetic retinopathy via inhibiting oxidative stress-mediated Wnt/β-catenin pathway activation.
Liu Q; Zhang X; Cheng R; Ma JX; Yi J; Li J
Cell Tissue Res; 2019 May; 376(2):165-177. PubMed ID: 30610453
[TBL] [Abstract][Full Text] [Related]
18. Diabetic retinopathy pathogenesis and the ameliorating effects of melatonin; involvement of autophagy, inflammation and oxidative stress.
Dehdashtian E; Mehrzadi S; Yousefi B; Hosseinzadeh A; Reiter RJ; Safa M; Ghaznavi H; Naseripour M
Life Sci; 2018 Jan; 193():20-33. PubMed ID: 29203148
[TBL] [Abstract][Full Text] [Related]
19. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
20. Effect of bone marrow mesenchymal stem cells-derived exosomes on diabetes-induced retinal injury: Implication of Wnt/ b-catenin signaling pathway.
Ebrahim N; El-Halim HEA; Helal OK; El-Azab NE; Badr OAM; Hassouna A; Saihati HAA; Aborayah NH; Emam HT; El-Wakeel HS; Aljasir M; El-Sherbiny M; Sarg NAS; Shaker GA; Mostafa O; Sabry D; Fouly MAK; Forsyth NR; Elsherbiny NM; Salim RF
Biomed Pharmacother; 2022 Oct; 154():113554. PubMed ID: 35987163
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
